06.02.23 Urinary CD163 Predicts Complete Renal Response with Zetomipzomib Treatment in the Open-label MISSION Phase 2 Study in Patients with Lupus Nephritis. European Alliance of Associations for Rheumatology 2023 Congress (EULAR 2023) .
